News 11 Oct. 2023
Curtis Team Instrumental in Shareholder Approval of a New Multilateral Treaty to Transform Pan-African Housing Finance Institution Shelter Afrique into a Development Bank
more
Event 23 Aug. 2023
Partner Borzu Sabahi Speaks at the 52nd IDRI Professional Accreditation & Membership Programme
Event 18 Aug. 2023
Partner Borzu Sabahi Speaks at FDI Moot Shenzhen
News 25 Jul. 2023
Partner Eric Gilioli Ranked in Top 10 Influential Energy & Natural Resources Lawyers in Kazakhstan in Business Today
Article 22 Aug. 2023
Fuad Zarbiyev Publishes Article in Journal of International Economic Law
Client Alert 14 Aug. 2023
The EU’s Market in Crypto Assets (MiCA) Regulation: The Highlights
Event 22 Aug. 2023
Partner Dr. Claudia Frutos-Peterson to Speak at Arbitration and ADR Commission of the ICC Mexico
Event 11 Jul. 2023
Partner Elisa Botero Speaks on the Role of the ICC in Investment Disputes
News 15 Aug. 2023
Legal Reader Publishes Article on Dr. Majed Alotaibi’s Arrival as Senior Counsel in Curtis’ Riyadh Office
News 31 Jul. 2023
Curtis Welcomes Senior Saudi Advisor, Dr. Majed Alotaibi, to its Riyadh Office
News 24 Aug. 2023
Curtis Attorneys Quoted in CoinDesk on FTX Founder Sam Bankman-Fried’s Strategy Ahead of His Criminal Trial
News 06 Mar. 2023
Russia Sanctions at the First Anniversary: An Overview of Current Sanctions in the US, UK, and EU and How Global Companies Can Navigate Evolving and Conflicting Sanctions Regimes
Client Alert 30 Aug. 2022
The EU Adopts the “Maintenance and Alignment” Sanctions Package
Client Alert 24 Jun. 2021
Update on Virtual Notarization (Executive Order 202.7) During the COVID-19 (Coronavirus) Pandemic (Updated: June 24, 2021) — U.S. Insight
Update on Virtual Witnessing (New York Executive Order 202.14) During The COVID-19 (Coronavirus) Pandemic (Updated: June 24, 2021) — U.S. Insight
News 15 May. 2013
Two Curtis Transactions were honored at the 5th Annual International M&A Advisor Awards, which recognizes the leading cross-border transactions, restructurings and deal financings globally.
The $6.1 Billion Acquisition of Viterra by Glencore was chosen as the Corporate & Strategic Acquisition of the Year (Over $1 Billion). The acquisition reinforces Glencore International's position as one of the world's leading commodity suppliers, giving Swiss-based Glencore immediate critical mass in the key grain markets of North America through Viterra's substantial Canadian operations. The Curtis team counseling Glencore in this acquisition included partners Matias Vega and Jeffrey Ostrager, counsels Raymond T. Hum and Susana Namnum, and associates Ryan Hansen, Martin Brown and Kreg Katoski (all from the Corporate group); partner Jeffrey Zuckerman and associate Ross Bidlingmaier (Antitrust/Competition) and partner James Durling (International Trade); partner Andrew Otis (Environmental); counsel Kuang-Chu Chiang and associate Rebecca Gidel (Tax); counsel Catherine Baecher (Real Estate), and partner Javier Hernandez (Employee Benefits).
The Acquisition of Eclipse Therapeutics by Bionomics Ltd. Was chosen as the M&A Deal of the Year (between $10 million and $50 million). As a result of the deal, Bionomics will gain an important strategic base in the United States, the world's largest pharmaceutical market, with the acquisition. The addition of Eclipse will expand Bionomics' oncology pipeline and establish the company as a global leader at the forefront of cancer stem cell therapeutics. The Curtis team was led by partner Lawrence Goodman and associates Douglas Glazer and Joshua Holt from the Corporate M&A group, partner Alan Berlin and counsel Kuang-Chu Chiang from the Tax group, and counsel Eric Stenshoel from the Intellectual Property practice.
Mergers and Acquisitions
Catherine M. Baecher
Partner
James Durling
Douglas Ian Glazer
Lawrence Goodman
Ryan Christopher Hansen
Javier Hernandez
Susana M. Namnum
Counsel
Eric Stenshoel
Matias A. Vega
We use cookies on our website to enhance your browsing experience, match your interests and assess our website performance. We do not share information with any third-party for marketing purposes. Please view our privacy policy to learn more about the use of cookies on our website. By continuing to browse our website, you consent to our use of cookies.